Galecto Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
GLTO Nasdaq 8731 https://galecto.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galecto Inc

Galecto, Inc. (GLTO) Upgraded to Strong Buy: What Does It Mean for the Stock? - Feb 14th, 2024 5:00 pm
What Makes Galecto, Inc. (GLTO) a New Strong Buy Stock - Jan 9th, 2024 9:57 pm
Will Galecto (NASDAQ:GLTO) Spend Its Cash Wisely? - Dec 30th, 2023 1:53 pm
Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis - Dec 21st, 2023 9:05 pm
Galecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 Trial - Oct 23rd, 2023 12:00 pm
Spotify downgraded, Tractor Supply upgraded: Wall Street's top analyst calls - Sep 28th, 2023 1:49 pm
Galecto Announces Plans to Explore Strategic Alternatives - Sep 26th, 2023 8:01 pm
Galecto to Present at Investor Conferences in September - Aug 31st, 2023 3:00 pm
OrbiMed Advisors LLC Reduces Stake in Galecto Inc - Aug 17th, 2023 11:01 pm
Biotech Stock Roundup: GLTO Plunges on Setback, BLUE Offers Updates & More - Aug 17th, 2023 12:58 pm
Galecto (GLTO) Down 71% as Lung Disease Candidate Fails - Aug 16th, 2023 11:46 am
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis - Aug 15th, 2023 11:30 am
Galecto Reports Second Quarter Operating and Financial Results - Jul 31st, 2023 8:05 pm
These 2 ‘Strong Buy’ Penny Stocks Could Go Boom, Say Analysts - Jul 25th, 2023 1:59 pm
Galecto Set to Join Russell Microcap® Index - Jun 20th, 2023 12:58 pm
Galecto to Present at the Upcoming Jefferies Healthcare Conference - May 30th, 2023 12:00 pm
Galecto Completes Dosing in 52-Week Phase 2b GALACTIC-1 Trial of GB0139 in Idiopathic Pulmonary Fibrosis - May 23rd, 2023 12:30 pm
Companies Like Galecto (NASDAQ:GLTO) Could Be Quite Risky - May 20th, 2023 12:54 pm
Galecto to Present Poster at Upcoming ATS 2023 International Conference - May 17th, 2023 8:01 pm
Galecto Reports First Quarter Operating and Financial Results - Apr 28th, 2023 12:00 pm